Trial Profile
A Phase 2, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 25 Nov 2015
Price :
$35
*
At a glance
- Drugs Iloprost (Primary)
- Indications Pulmonary hypertension
- Focus Pharmacodynamics
- Sponsors Actelion Pharmaceuticals
- 29 Mar 2014 New trial record
- 06 Feb 2013
- 11 Jan 2012